Fighting drug-resistant bacteria with a new genre of antibodies

Anti-Cancer Antibodies (Photo credit: PNNL – Pacific Northwest National Laboratory)

Laboratory experiments showed that the colloid antibodies attached to and inactivated only their intended targets without harming other cells

In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of selective antimicrobial agents that do not rely on traditional antibiotics. Their report on these synthetic colloid particles, which can be custom-designed to recognize the shape of specific kinds of bacteria and inactivate them, appears in the Journal of the American Chemical Society.

Vesselin Paunov and colleagues point out that many bacteria have developed resistance to existing antibiotics. They sought a new approach — one that bacteria would be unable to elude by mutating into drug-resistant forms. Their inspiration was the antibodies that the immune system produces when microbes invade the body. Those antibodies patrol the body for microbes and bind to their surfaces, triggering a chain of events in which the body’s immune system attacks and destroys the microbes.

Paunov’s team describes development and successful tests of synthetic colloid particles, called “colloid antibodies.” Colloids are materials in which tiny particles of one material are dispersed in another material. Milk is a colloid in which globules of fat are spread throughout water and other materials. The colloid antibody particles are shells packed with a killing agent. They are designed to recognize and bind to specific bacteria.

Laboratory experiments showed that the colloid antibodies attached to and inactivated only their intended targets without harming other cells. “We anticipate that similar shape selective colloid antibodies can potentially become a powerful weapon in the fight against antibiotic-resistant bacteria,” say the researchers. “They can also find applications as non-toxic antibacterial agents, preventing growth of harmful bacteria in various formulations.”

See Also


The Latest Bing News on:
Drug resistant bacteria
The Latest Google Headlines on:
Drug resistant bacteria
[google_news title=”” keyword=”drug resistant bacteria” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]
The Latest Bing News on:
Colloid antibodies
  • The Antibody Initiative Antivenom
    on May 10, 2024 at 9:08 pm

    Antivenom (often spelled “antivenin”) is an antibody product that can disable a particular venom’s toxins. If injected quickly after a bite or sting, the antibodies in antivenom neutralize the venom, ...

  • Hepatitis B Antibodies: A Guide to Testing
    on May 9, 2024 at 4:59 pm

    Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...

  • News tagged with colloids
    on May 7, 2024 at 5:00 pm

    Daniela Kraft's group has succeeded in creating a network of microparticles that is both strong and completely flexible. This may sound simple, yet they are the first in the world to succeed in ...

  • ImmunoPrecise Antibodies Ltd. (IPA)
    on April 26, 2024 at 9:00 am

    VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its ...

  • Therapeutic Antibodies – Webinars and Online Events
    on April 19, 2024 at 11:55 am

    This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe ...

  • Production of monoclonal antibodies - Higher
    on February 13, 2024 at 9:10 am

    Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

  • What You Need To Know About Your Spleen
    on January 19, 2024 at 1:49 pm

    The white pulp also helps produce antibodies. While the spleen is the largest organ ... magnetic resonance imaging (MRI), positron emission tomography (PET) scans, liver-spleen colloid scanning, and ...

  • Colloid & Interface Science Group
    on February 4, 2022 at 2:24 am

    The Colloid and Interface Science Group is one of the RSC's many Interest Groups. The Interest Groups are member driven groups which exist to benefit RSC members, and the wider chemical science ...

  • 36% Of Those Who Had Covid-19 Didn’t Develop Antibodies, Study Says
    on September 5, 2021 at 9:32 am

    A study just published in the journal Emerging Infectious Disease found that 36% of those who had had Covid-19 didn’t have antibodies against the severe acute respiratory syndrome coronavirus 2 ...

  • How long do Covid antibodies last after infection?
    on November 8, 2020 at 8:00 pm

    Coronavirus antibodies drop by half in less than 90 days and fall faster in younger adults, an ongoing study of staff at the John Radcliffe's hospital trust has revealed. The paper, published as a ...

The Latest Google Headlines on:
Colloid antibodies

[google_news title=”” keyword=”colloid antibodies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

What's Your Reaction?
Don't Like it!
I Like it!
Scroll To Top